In 1993, Israel's drug exports (including pharmaceutical chemicals) and imports (finished products only) were almost identical at around $220 million each. But in 1994, exports rose more than 20% to $267 million while imports increased by 14.5% to $250 million.
Adding in imports of raw materials, the total imports of pharmaceuticals reached $307 million in 1994. However, the export figures do not include biotechnology products which, with diagnostics, rose by a modest 5% to reach $70 million during 1994. Another factor to bear in mind in evaluating the trade balance is that most imports come from hard European currency markets.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze